BiotechTube
Home/Arpeggio Biosciences/Andy Ren, PhD
AR

Andy Ren, PhD

Head of Drug Discovery

Arpeggio Biosciences

Therapeutic Areas

Oncology

Arpeggio Biosciences Pipeline

DrugIndicationPhase
NRF2 ProgramLung Cancer (implied)Pre-clinical
Transcriptomic Screening PlatformOncology & BeyondDiscovery

Leadership Team at Arpeggio Biosciences

JA
Joey Azofeifa, PhD
CEO & Co-founder
TR
Tim Read, PhD
Co-founder & Head of Discovery Biology
SG
Stefan Gross, PhD
Chief Scientific Officer
View full Arpeggio Biosciences profile